Abbott Laboratories Biotech Facility

Specifications - Abbott Laboratories Biotech Facility Barceloneta, Puerto Rico


Key Data
Order year2002
Project typeBiologics facility
Output chemicalsHumira (adalimumab) (CAT-derived human anti-TNFα [tumour necrosis factor α]) monoclonal antibody
LocationBarceloneta, Commonwealth of Puerto Rico
Estimated investment$450m
Construction started2003
Completion2005 (then validation took until April 2007)
Key Players
SponsorsAbbott Laboratories, Abbott Biotechnology Ltd
General contractorInsulation Specialties, Pharmabio, Cives Steel Company Corp, Industrial Sprinklers
EngineeringLG Scott
FinancingAbbott Laboratories and tax incentives from the Government of the Commonwealth of Puerto Rico


client logon
Home
Products & Services
Company A-Z
White Papers
Jobs & Careers
Press Releases
Advertise With Us
Events & Exhibitions
Newsletter
New On This Site
About Us
Atom FeedRSS Feed
What is RSS?